Guanze Medical Information Industry (Holding) Co., Ltd.
Detailed Investor Update: Mandatory Unconditional Cash Offer

Key Highlights from the Joint Announcement

• Mandatory Unconditional Cash Offer: Aristo Securities Limited, acting for FUNDE (Hong Kong) Investment Holdings Co., Limited, is making a mandatory unconditional cash offer to acquire all issued shares of Guanze Medical Information Industry (Holding) Co., Ltd. (Stock Code: 2427) – except those already owned or agreed to be acquired by FUNDE, its ultimate beneficial owners, and parties acting in concert.
• Composite Document Issued: The Composite Document, outlining the offer details, terms, expected timetable, and recommendations, was despatched to independent shareholders on 17 April 2026.
• Offer Timetable:
  • Offer opens: 17 April 2026
  • Latest time for acceptance: 4:00 p.m. on 8 May 2026
  • Results announcement: by 7:00 p.m. on 8 May 2026
  • Remittances for valid acceptances posted: by 19 May 2026
• Offer Terms: The cash offer is unconditional in all respects. Acceptances are irrevocable and cannot be withdrawn except under specific circumstances described in the Composite Document.
• Regulatory Requirements: The offer is made in accordance with the Hong Kong Takeovers Code and is open for at least 21 days from the date of the Composite Document. Any revision or extension of the offer triggers a new acceptance period of at least 14 days.
• Procedural Notes: Shareholders holding shares via CCASS should pay attention to timing requirements for acceptance. Any disruption due to severe weather (tropical cyclone, black rainstorm, or extreme conditions) may lead to rescheduling of key dates.
• Recommendations and Advice: Independent shareholders are strongly urged to read the Composite Document and Form of Acceptance, including recommendations from the Independent Board Committee and advice from the Independent Financial Adviser, before deciding whether to accept the offer.
• Dealing Restrictions: Associates of both FUNDE and Guanze Medical are reminded of dealing restrictions under the Takeovers Code and must disclose permitted dealings in company securities.

Investor Implications & Price-Sensitive Information

• Potential Share Price Impact: The unconditional nature of the cash offer is significant. Such offers often result in immediate share price adjustments as investors reassess the value of their holdings, particularly since all independent shareholders are eligible to tender their shares for cash. The certainty of the offer may support the share price, especially if the offer price represents a premium to current market prices.
• Irrevocable Acceptance: Once shareholders accept the offer, they cannot withdraw unless specific withdrawal rights arise as per the Composite Document. Investors must be certain in their decision to tender shares.
• Timely Action Required: All acceptances must be submitted by 4:00 p.m. on 8 May 2026. Missing this deadline may mean missing the opportunity to participate in the cash offer.
• Risk of Deal Extension/Revisions: If the offer is extended or revised, all shareholders (including those who have already accepted) will be entitled to accept the revised terms, which could affect the final consideration and impact the share price.
• Weather-Related Risks: Key dates may change if severe weather occurs. Investors should monitor company announcements closely if such events arise.
• Composite Document Availability: Shareholders are advised to access the Composite Document and Form of Acceptance through the Stock Exchange and company websites to ensure they have all information necessary to make an informed decision.

Board and Director Statements

• Both the Offeror and the Company directors accept full responsibility for the accuracy and completeness of the announcement, with clear delineation of responsibility for information relating to their respective entities.
• The respective Boards have confirmed that opinions expressed are the result of due and careful consideration.

Action Points for Shareholders

• Read the Composite Document and Form of Acceptance carefully.
• Seek professional advice if unsure about the implications or actions to take.
• Monitor company and regulatory announcements for any changes to the offer timetable or terms, especially in the event of adverse weather.
• Be aware of dealing restrictions if you are an associate of either the Offeror or the Company.

Conclusion

The launch of a mandatory unconditional cash offer for all issued shares (except those already owned or agreed to be acquired) of Guanze Medical Information Industry (Holding) Co., Ltd. is a highly significant and price-sensitive event. The certainty and scope of the offer, as well as its unconditional terms, have the potential to move the share price, and all investors should act promptly and with full information.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their professional advisers before making any investment decision in relation to Guanze Medical Information Industry (Holding) Co., Ltd. The company and the Offeror accept responsibility for the accuracy of information as stated in the official joint announcement. The English version prevails in case of any inconsistency with the Chinese text.

View GUANZE MEDICAL Historical chart here